Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science.

We offer a combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas. This convergence of offerings allows us to deliver depth and breadth in science, with data and insight you can trust to progress your drug discovery program from early discovery to IND.

 

Featured Speakers

Headshot of Kim Dekermendjian

Kim Dekermendjian
Associated Business Development
Charles River


Headshot of Chris Hurley

Chris Hurley
Director of Client Services
Charles River


Headshot of Keith Sutton

Keith Sutton
Group Leader, Pharmacology
Charles River